Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease  Vered Abitbol,

Similar presentations


Presentation on theme: "A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease  Vered Abitbol,"— Presentation transcript:

1 A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease  Vered Abitbol, Karine Briot, Christian Roux, Carine Roy, Philippe Seksik, Antoine Charachon, Yoram Bouhnik, Benoit Coffin, Matthieu Allez, Dominique Lamarque, Stanislas Chaussade  Clinical Gastroenterology and Hepatology  Volume 5, Issue 10, Pages (October 2007) DOI: /j.cgh Copyright © 2007 AGA Institute Terms and Conditions

2 Figure 1 Trial profile. Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh ) Copyright © 2007 AGA Institute Terms and Conditions

3 Figure 2 BMD changes during 1 year in placebo and clodronate groups.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh ) Copyright © 2007 AGA Institute Terms and Conditions


Download ppt "A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease  Vered Abitbol,"

Similar presentations


Ads by Google